Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
Tiong IS, Wall M, Bajel A, Kalro A, Fleming S, Roberts AW, Thiagarajah N, Chua CC, Latimer M, Yeung D, Marlton P, Johnston A, Enjeti A, Fong CY, Cull G, Larsen S, Kennedy G, Schwarer A, Kipp D, Ramanathan S, Verner E, Tiley C, Morris E, Hahn U, Moore J, Taper J, Purtill D, Warburton P, Stevenson W, Murphy N, Tan P, Beligaswatte A, Mutsando H, Hertzberg M, Shortt J, Szabo F, Dunne K, Wei AH; Australasian Leukaemia and Lymphoma Group (ALLG). Tiong IS, et al. Among authors: larsen s. Blood Cancer J. 2024 Mar 26;14(1):54. doi: 10.1038/s41408-024-00996-x. Blood Cancer J. 2024. PMID: 38531863 Free PMC article.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Iland HJ, Bradstock K, Supple SG, Catalano A, Collins M, Hertzberg M, Browett P, Grigg A, Firkin F, Hugman A, Reynolds J, Di Iulio J, Tiley C, Taylor K, Filshie R, Seldon M, Taper J, Szer J, Moore J, Bashford J, Seymour JF; Australasian Leukaemia and Lymphoma Group. Iland HJ, et al. Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19. Blood. 2012. PMID: 22715121 Free article. Clinical Trial.
Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
Purtill D, Antonenas V, Chiappini P, Tong D, O'Flaherty E, Bajel A, Kabani K, Larsen S, Tan S, Hutchins C, Curtis DJ, Kennedy GA, Watson AM, Bai L, Greenwood M, Gottlieb DJ, Hamad N. Purtill D, et al. Among authors: larsen s. Blood Adv. 2020 Sep 8;4(17):4147-4150. doi: 10.1182/bloodadvances.2020002431. Blood Adv. 2020. PMID: 32886750 Free PMC article.
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR.
Kliman D, Tran S, Kennedy G, Curley C, McLean A, Gottlieb D, Kwan J, Ritchie D, Chee L, Spencer A, Purtill D, Bardy P, Larsen S, Chien N, Perera T, Greenwood M, Hamad N, Moore J. Kliman D, et al. Among authors: larsen s. Bone Marrow Transplant. 2022 Jun;57(6):982-989. doi: 10.1038/s41409-022-01683-w. Epub 2022 Apr 19. Bone Marrow Transplant. 2022. PMID: 35440804
Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia.
Lindsay J, Kabir M, Gilroy N, Dyer G, Brice L, Moore J, Greenwood M, Hertzberg M, Gottlieb D, Larsen SR, Hogg M, Brown L, Huang G, Tan J, Ward C, Kerridge I. Lindsay J, et al. Cancer Med. 2016 Dec;5(12):3606-3614. doi: 10.1002/cam4.889. Epub 2016 Oct 27. Cancer Med. 2016. PMID: 27790858 Free PMC article.
Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry.
Lwin Y, Kennedy G, Gottlieb D, Kwan J, Ritchie D, Szer J, Milliken S, Browett P, Spencer A, Butler A, Bardy P, Greenwood M, Perera T, He S, McEwan A, Larsen S, Lai H, Purtill D, Tran S, Aarons D, Hamad N. Lwin Y, et al. Among authors: larsen s. Biol Blood Marrow Transplant. 2020 Dec;26(12):2252-2261. doi: 10.1016/j.bbmt.2020.08.024. Epub 2020 Aug 27. Biol Blood Marrow Transplant. 2020. PMID: 32861814 Free article.
What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia.
Dyer G, Gilroy N, Brown L, Hogg M, Brice L, Kabir M, Greenwood M, Larsen SR, Moore J, Hertzberg M, Kwan J, Huang G, Tan J, Ward C, Kerridge I. Dyer G, et al. Biol Blood Marrow Transplant. 2016 Apr;22(4):731-743. doi: 10.1016/j.bbmt.2015.12.019. Epub 2015 Dec 30. Biol Blood Marrow Transplant. 2016. PMID: 26746819 Free article.
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.
Othman J, Greenwood M, Moore J, Larsen S, Watson AM, Arthur C, Bhattacharyya A, Bilmon I, Blyth E, Bryant A, Bryant C, Dunlop L, Fay K, Gibson J, Hamad N, Kerridge I, Kwan J, Ma D, Micklethwaite K, Milliken S, Panicker S, Stevenson W, Withers B, Wilcox L, Tran S, Gottlieb DJ. Othman J, et al. Among authors: larsen s. Biol Blood Marrow Transplant. 2020 Oct;26(10):1868-1875. doi: 10.1016/j.bbmt.2020.06.030. Epub 2020 Jul 5. Biol Blood Marrow Transplant. 2020. PMID: 32640314 Free article.
2,312 results